✦ LIBER ✦

A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer

✍ Scribed by Agelaki, S.; Kakolyris, S.; Palamidas, Ph.; Kouroussis, Ch.; Mavroudis, D.; Kalbakis, K.; Georgoulias, V.; Raptis, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose escalation study of vinorel

✍ Matthew A Beldner; Carol A Sherman; Mark R Green; Elizabeth Garrett-Mayer; Uzair 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 278 KB

Phase II study of Topotecan (TC) in pati

✍ Tvede, K.; Ardizzoni, A.; Dombemowsky, P.; Postmus, P.; Buitenhuis, M.; Wanders, 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phase I study of escalating doses of oxa

✍ Bidoli, P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase II study of high-dose epirubicin i

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Dose escalation study of irinotecan comb

✍ Koji Takeda; Shunichi Negoro; Nobuhide Takifuji; Takashi Nitta; Naruo Yoshimura; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 77 KB

A Phase II Study of Topotecan in Patient

✍ Koji Takeda; Shunichi Negoro; Toshiyuki Sawa; Kazuhiko Nakagawa; Masaaki Kawahar 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB